L Flint Selected Research

Antiemetics

1/2018

Intravenous fosfomycin for pulmonary exacerbation of cystic fibrosis: Real life experience of a large adult CF centre.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L Flint Research Topics

Disease

1	Nausea 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Drug Hypersensitivity (Drug Allergy) 01/2018
1	Cystic Fibrosis (Mucoviscidosis) 01/2018
1	Osteomyelitis 02/2016
1	Persistent Infection 02/2016
1	Infections 02/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2013
1	Atherosclerotic Plaque (Atheroma) 04/2001
1	Coronary Artery Disease (Coronary Atherosclerosis) 04/2001
1	Myocardial Infarction 04/2001
1	Thrombosis (Thrombus) 04/2001
1	Gunshot Wounds (Gunshot Wound) 03/2001
1	Wounds and Injuries (Trauma) 03/2001

Drug/Important Bio-Agent (IBA)

2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 02/2016
2	Pharmaceutical PreparationsIBA 01/2018 - 03/2001
1	Fosfomycin FDA Link 01/2018
1	AntiemeticsIBA 01/2018
1	Rifampin (Rifampicin)FDA LinkGeneric 02/2016
1	Clindamycin (Cleocin)FDA LinkGeneric 02/2016
1	Gentamicins (Gentamicin)FDA LinkGeneric 02/2016
1	Moxifloxacin (Avelox)FDA Link 02/2016
1	Infliximab (Remicade)FDA Link 06/2013
1	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2001
1	OF 743IBA 03/2001

Therapy/Procedure

3	Therapeutics 01/2018 - 06/2013
1	Thrombolytic Therapy 04/2001